Literature DB >> 27148956

Using the SAEM algorithm for mechanistic joint models characterizing the relationship between nonlinear PSA kinetics and survival in prostate cancer patients.

Solène Desmée1,2, France Mentré1,2, Christine Veyrat-Follet3, Bernard Sébastien4, Jérémie Guedj1,2.   

Abstract

Joint modeling is increasingly popular for investigating the relationship between longitudinal and time-to-event data. However, numerical complexity often restricts this approach to linear models for the longitudinal part. Here, we use a novel development of the Stochastic-Approximation Expectation Maximization algorithm that allows joint models defined by nonlinear mixed-effect models. In the context of chemotherapy in metastatic prostate cancer, we show that a variety of patterns for the Prostate Specific Antigen (PSA) kinetics can be captured by using a mechanistic model defined by nonlinear ordinary differential equations. The use of a mechanistic model predicts that biological quantities that cannot be observed, such as treatment-sensitive and treatment-resistant cells, may have a larger impact than PSA value on survival. This suggests that mechanistic joint models could constitute a relevant approach to evaluate the efficacy of treatment and to improve the prediction of survival in patients.
© 2016, The International Biometric Society.

Entities:  

Keywords:  Joint model; Metastatic prostate cancer; Nonlinear mixed effect model; Prostate specific antigen; SAEM algorithm; Survival

Mesh:

Substances:

Year:  2016        PMID: 27148956      PMCID: PMC5654727          DOI: 10.1111/biom.12537

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  19 in total

1.  Joint modeling of the clinical progression and of the biomarkers' dynamics using a mechanistic model.

Authors:  Jeremie Guedj; Rodolphe Thiébaut; Daniel Commenges
Journal:  Biometrics       Date:  2011-03       Impact factor: 2.571

2.  NIMROD: a program for inference via a normal approximation of the posterior in models with random effects based on ordinary differential equations.

Authors:  Mélanie Prague; Daniel Commenges; Jérémie Guedj; Julia Drylewicz; Rodolphe Thiébaut
Journal:  Comput Methods Programs Biomed       Date:  2013-06-10       Impact factor: 5.428

3.  Dynamic predictions and prospective accuracy in joint models for longitudinal and time-to-event data.

Authors:  Dimitris Rizopoulos
Journal:  Biometrics       Date:  2011-02-09       Impact factor: 2.571

4.  Maximum likelihood estimation of long-term HIV dynamic models and antiviral response.

Authors:  Marc Lavielle; Adeline Samson; Ana Karina Fermin; France Mentré
Journal:  Biometrics       Date:  2011-03       Impact factor: 2.571

5.  Model selection and diagnostics for joint modeling of survival and longitudinal data with crossing hazard rate functions.

Authors:  Ka Young Park; Peihua Qiu
Journal:  Stat Med       Date:  2014-07-07       Impact factor: 2.373

Review 6.  Modelling hepatitis C therapy--predicting effects of treatment.

Authors:  Alan S Perelson; Jeremie Guedj
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-30       Impact factor: 46.802

7.  Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial.

Authors:  Ian F Tannock; Karim Fizazi; Sergey Ivanov; Camilla Thellenberg Karlsson; Aude Fléchon; Iwona Skoneczna; Francisco Orlandi; Gwenaelle Gravis; Vsevolod Matveev; Sevil Bavbek; Thierry Gil; Luciano Viana; Osvaldo Arén; Oleg Karyakin; Tony Elliott; Alison Birtle; Emmanuelle Magherini; Laurence Hatteville; Daniel Petrylak; Bertrand Tombal; Mark Rosenthal
Journal:  Lancet Oncol       Date:  2013-06-04       Impact factor: 41.316

8.  Nonlinear Mixed-effect Models for Prostate-specific Antigen Kinetics and Link with Survival in the Context of Metastatic Prostate Cancer: A Comparison by Simulation of Two-stage and Joint Approaches.

Authors:  Solène Desmée; France Mentré; Christine Veyrat-Follet; Jérémie Guedj
Journal:  AAPS J       Date:  2015-03-05       Impact factor: 4.009

Review 9.  Mode of action of docetaxel - a basis for combination with novel anticancer agents.

Authors:  Roy S Herbst; Fadlo R Khuri
Journal:  Cancer Treat Rev       Date:  2003-10       Impact factor: 12.111

10.  Tumor growth rates derived from data for patients in a clinical trial correlate strongly with patient survival: a novel strategy for evaluation of clinical trial data.

Authors:  Wilfred D Stein; William Doug Figg; William Dahut; Aryeh D Stein; Moshe B Hoshen; Doug Price; Susan E Bates; Tito Fojo
Journal:  Oncologist       Date:  2008-10-06
View more
  7 in total

1.  Bayesian Individual Dynamic Predictions with Uncertainty of Longitudinal Biomarkers and Risks of Survival Events in a Joint Modelling Framework: a Comparison Between Stan, Monolix, and NONMEM.

Authors:  François Riglet; France Mentre; Christine Veyrat-Follet; Julie Bertrand
Journal:  AAPS J       Date:  2020-02-19       Impact factor: 4.009

2.  Development and performance of npde for the evaluation of time-to-event models.

Authors:  M Cerou; M Lavielle; K Brendel; M Chenel; E Comets
Journal:  Pharm Res       Date:  2018-01-09       Impact factor: 4.200

3.  Nonlinear joint models for individual dynamic prediction of risk of death using Hamiltonian Monte Carlo: application to metastatic prostate cancer.

Authors:  Solène Desmée; France Mentré; Christine Veyrat-Follet; Bernard Sébastien; Jérémie Guedj
Journal:  BMC Med Res Methodol       Date:  2017-07-17       Impact factor: 4.615

Review 4.  Joint models for dynamic prediction in localised prostate cancer: a literature review.

Authors:  Harry Parr; Emma Hall; Nuria Porta
Journal:  BMC Med Res Methodol       Date:  2022-09-19       Impact factor: 4.612

5.  A workflow for the joint modeling of longitudinal and event data in the development of therapeutics: Tools, statistical methods, and diagnostics.

Authors:  Kirill Zhudenkov; Sergey Gavrilov; Alina Sofronova; Oleg Stepanov; Nataliya Kudryashova; Gabriel Helmlinger; Kirill Peskov
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-02-21

6.  Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies.

Authors:  Vincent Madelain; Sylvain Baize; Frédéric Jacquot; Stéphanie Reynard; Alexandra Fizet; Stephane Barron; Caroline Solas; Bruno Lacarelle; Caroline Carbonnelle; France Mentré; Hervé Raoul; Xavier de Lamballerie; Jérémie Guedj
Journal:  Nat Commun       Date:  2018-10-01       Impact factor: 14.919

Review 7.  Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials.

Authors:  Vincent Madelain; France Mentré; Sylvain Baize; Xavier Anglaret; Cédric Laouénan; Lisa Oestereich; Thi Huyen Tram Nguyen; Denis Malvy; Géraldine Piorkowski; Frederik Graw; Stephan Günther; Hervé Raoul; Xavier de Lamballerie; Jérémie Guedj
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-04-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.